Clinical Trial Update: Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib [Phase 1, Phase 2]

View source ↗

Summary

This update covers a Phase 1/2 clinical trial evaluating autologous vaccination for stage 4 renal cell carcinoma in combination with Sunitinib. The sponsor is H…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Autologous cancer cell vaccine
• Sutent (sunitinib)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Renal Cell Cancer | Phase 1, Phase 2 | Status: UNKNOWN